BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29807933)

  • 1. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
    Mehra MR; Salerno C; Cleveland JC; Pinney S; Yuzefpolskaya M; Milano CA; Itoh A; Goldstein DJ; Uriel N; Gulati S; Pagani FD; John R; Adamson R; Bogaev R; Thohan V; Chuang J; Sood P; Goates S; Silvestry SC
    Circulation; 2018 Oct; 138(18):1923-1934. PubMed ID: 29807933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
    Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR
    Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.
    Colombo PC; Mehra MR; Goldstein DJ; Estep JD; Salerno C; Jorde UP; Cowger JA; Cleveland JC; Uriel N; Sayer G; Skipper ER; Downey FX; Ono M; Hooker R; Anyanwu AC; Givertz MM; Mahr C; Topuria I; Somo SI; Crandall DL; Horstmanshof DA
    Circulation; 2019 Jan; 139(2):155-168. PubMed ID: 30586698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial.
    Vidula H; Takeda K; Estep JD; Silvestry SC; Milano C; Cleveland JC; Goldstein DJ; Uriel N; Kormos RL; Dirckx N; Mehra MR
    JACC Heart Fail; 2022 Jul; 10(7):470-481. PubMed ID: 35772857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients.
    Cowger JA; Naka Y; Aaronson KD; Horstmanshof D; Gulati S; Rinde-Hoffman D; Pinney S; Adatya S; Farrar DJ; Jorde UP;
    J Heart Lung Transplant; 2018 Jan; 37(1):15-24. PubMed ID: 29153637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.
    Mehra MR; Uriel N; Naka Y; Cleveland JC; Yuzefpolskaya M; Salerno CT; Walsh MN; Milano CA; Patel CB; Hutchins SW; Ransom J; Ewald GA; Itoh A; Raval NY; Silvestry SC; Cogswell R; John R; Bhimaraj A; Bruckner BA; Lowes BD; Um JY; Jeevanandam V; Sayer G; Mangi AA; Molina EJ; Sheikh F; Aaronson K; Pagani FD; Cotts WG; Tatooles AJ; Babu A; Chomsky D; Katz JN; Tessmann PB; Dean D; Krishnamoorthy A; Chuang J; Topuria I; Sood P; Goldstein DJ;
    N Engl J Med; 2019 Apr; 380(17):1618-1627. PubMed ID: 30883052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?
    Florisson DS; Conte SM; De Bono JA; Newcomb AE
    Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
    Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR
    J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial.
    Goldstein DJ; Mehra MR; Naka Y; Salerno C; Uriel N; Dean D; Itoh A; Pagani FD; Skipper ER; Bhat G; Raval N; Bruckner BA; Estep JD; Cogswell R; Milano C; Fendelander L; O'Connell JB; Cleveland J;
    J Heart Lung Transplant; 2018 Jan; 37(1):7-14. PubMed ID: 29154131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure.
    Mehra MR; Naka Y; Uriel N; Goldstein DJ; Cleveland JC; Colombo PC; Walsh MN; Milano CA; Patel CB; Jorde UP; Pagani FD; Aaronson KD; Dean DA; McCants K; Itoh A; Ewald GA; Horstmanshof D; Long JW; Salerno C;
    N Engl J Med; 2017 Feb; 376(5):440-450. PubMed ID: 27959709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure.
    Mehra MR; Goldstein DJ; Uriel N; Cleveland JC; Yuzefpolskaya M; Salerno C; Walsh MN; Milano CA; Patel CB; Ewald GA; Itoh A; Dean D; Krishnamoorthy A; Cotts WG; Tatooles AJ; Jorde UP; Bruckner BA; Estep JD; Jeevanandam V; Sayer G; Horstmanshof D; Long JW; Gulati S; Skipper ER; O'Connell JB; Heatley G; Sood P; Naka Y;
    N Engl J Med; 2018 Apr; 378(15):1386-1395. PubMed ID: 29526139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants.
    Mehra MR; Cleveland JC; Uriel N; Cowger JA; Hall S; Horstmanshof D; Naka Y; Salerno CT; Chuang J; Williams C; Goldstein DJ;
    Eur J Heart Fail; 2021 Aug; 23(8):1392-1400. PubMed ID: 33932272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial.
    Mehra MR; Goldstein DJ; Cleveland JC; Cowger JA; Hall S; Salerno CT; Naka Y; Horstmanshof D; Chuang J; Wang A; Uriel N
    JAMA; 2022 Sep; 328(12):1233-1242. PubMed ID: 36074476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De Novo Human Leukocyte Antigen Allosensitization in Heartmate 3 Versus Heartmate II Left Ventricular Assist Device Recipients.
    Jain R; Habal MV; Clerkin KJ; Latif F; Restaino SW; Zorn E; Takeda K; Naka Y; Yuzefpolskaya M; Farr MA; Colombo PC; Sayer GT; Uriel N; Topkara VK
    ASAIO J; 2022 Feb; 68(2):226-232. PubMed ID: 33883507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device: An Analysis From the MOMENTUM 3 Trial.
    Sheikh FH; Ravichandran AK; Goldstein DJ; Agarwal R; Ransom J; Bansal A; Kim G; Cleveland JC; Uriel N; Sheridan BC; Chomsky D; Patel SR; Dirckx N; Franke A; Mehra MR
    Circ Heart Fail; 2021 Oct; 14(10):e008360. PubMed ID: 34525837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
    Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial.
    Patel CB; Blue L; Cagliostro B; Bailey SH; Entwistle JW; John R; Thohan V; Cleveland JC; Goldstein DJ; Uriel N; Su X; Somo SI; Sood P; Mehra MR
    J Heart Lung Transplant; 2020 Aug; 39(8):774-781. PubMed ID: 32276809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and clinical correlates of de-novo aortic regurgitation with a fully magnetically levitated left ventricular assist device: a MOMENTUM 3 trial portfolio analysis.
    Uriel N; Milano C; Agarwal R; Lee S; Cleveland J; Goldstein D; Wang A; Crandall D; Mehra MR
    Eur J Heart Fail; 2023 Feb; 25(2):286-294. PubMed ID: 36404406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Device exchange from HeartMate II to HeartMate 3 left ventricular assist device.
    Takeda K; Takayama H; Sanchez J; Cevasco M; Yuzefpolskaya M; Colombo PC; Naka Y
    Interact Cardiovasc Thorac Surg; 2019 Sep; 29(3):430-433. PubMed ID: 31143932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.